Screening of tumor diseases of reproductive system: possibilities and prospects

The urgency of reproductive system tumor disease (RSTD) screening is caused by high incidence rates, a tendency to renewal of youth, and unsatisfactory therapeutic results. In Russia, indicators of RSTD active detection and diagnosis during preinvasive and early stages remain low. Thus, such diseases adversely affect the women's quality of life, life expectancy and reproductive function. The objective of the paper is to establish the reasons for the inefficiency of RSTD screening analyzing the literature available. Results. Literature analysis of modern screening principles and methods has shown that the main reasons for unsatisfactory RSTD screening and early diagnosis are low screening rates, legislative framework inconsistency, maladjustment at the beginning and the end of examination as well as in screening interval, lack of a single information base where all survey results are recorded and stored, problems in data exchange based on undertaken studies, profound diagnostic limitations in different regions, lack of an integrated approach and a single national screening program. Conclusion. One of the possible solutions to the existing problem can be a comprehensive diagnostic examination with a simultaneous assessment of all organs of the reproductive system, including mammary glands, in order to timely identify RSTD, form risk groups for tumor pathology and correct management.